Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Informations

Home » Informations
  • Overcoming Venetoclax Resistance in CLL: A Novel BCL2/BCL-xL Dual-Efficacy Degrader Reshapes the Therapeutic Landscape丨EHA 2025

    In the high summer of 2025, the highly anticipated European Hematology Association (EHA) Annual Meeting was convened, bringing together top global experts in hematologic oncology to discuss cutting-edge progress and future directions in the field. In the Chronic Lymphocytic Leukemia (CLL) session, Dr. Daisy Diaz, a postdoctoral fellow from MD Anderson Cancer Center in the…

    2025.08.30
  • EHA 2025: Professor Alberto Orfao on Immune Mechanisms and Diagnostic Breakthroughs in Rare Diseases

    As a scholar with a research career spanning over 30 years, Professor Alberto Orfao began his lecture by expressing his profound gratitude. He attributed this honor to the hundreds of…

    2025.08.30
  • Pujiang Genitourinary Oncology Academic Conference 2025

    We are excited to share the upcoming Pujiang Genitourinary Oncology Academic Conference 2025 Webinar taking place on August 27, 2025. 14:00–15:30 (Dublin/London) | 15:00–16:30 CET | 21:00–22:30 CST This online…

    2025.08.26
  • BJH / JLB | Team of Professors Jianxiang Wang and Shaowei Qiu at the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Uncover Novel Mechanisms in t(8;21) AML and Identify Potential Therapeutic Targets

    Acute myeloid leukemia, subtype M2b (AML-M2b), was first identified in 1959 by Professor Chongli Yang at the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (CAMS), based on clinical features, bone marrow morphology, and cytology. He termed it “subacute granulocytic leukemia.” In 1973, Rowley and colleagues abroad reported the same leukemia…

    2025.08.22
  • A Warm Welcome from Prof. Francesco Giorgino | EASD 2025

    2025.08.22
  • Landmark Collaboration: CACA-LCC and ILCA Forge Strategic Partnership to Advance Global Hepatocellular Carcinoma Research and Treatment

    The pre-signing ceremony was graced by the presence of eminent hepatology experts, including Academician Jia Fan, Academician Gaojun Teng, Professor Jian Zhou, Professor Feng Shen, Professor Ming Kuang, Professor Weiping…

    2025.08.17
  • A Trans-Pacific Meeting of Minds: US–China Collaboration in Urology

    On July 10–11, 2025, Professor Steven Campbell, Chair of Urology at West Virginia University, visited the Sun Yat-sen University Cancer Center (SYSUCC) for a two-day academic exchange. His visit brought an international, cutting-edge perspective to SYSUCC’s Department of Urology while also showcasing the department’s achievements to peers worldwide.

    2025.08.15
  • Highlights of ISEH 2025: Preview of China-Japan Joint Workshop on Stem Cells and Cell Therapy

    The 54th Annual Scientific Meeting of the International Society for Experimental Hematology (ISEH 2025) will be held in Kumamoto, Japan, from September 24 to 27, 2025. One of the major…

    2025.08.15
«previous next»
Recent Posts
  • The 14th Lu Daopei Hematology Forum丨Professor Huili Zhu: Evidence-Based Updates and Precision Prevention and Control — A Clinical Interpretation of the 7th Edition of the Guidelines for Invasive Fungal Disease in Hematologic Disorders
  • The 14th Lu Daopei Hematology Forum | Professor Hui Wang: Building the Foundation with Precision Diagnosis, Advancing with Intelligent Empowerment—The Clinical Value and Future Directions of Hematologic Laboratory Testing
  • The 14th Lu Daopei Hematology Forum | Peihua Lu: Fourteen Years of Staying True to the Mission and Embarking on a New Journey—The Value and Future of an Academic Platform for Hematology
  • The 14th Lu Daopei Hematology Forum | Dongchu Wang: Unlocking the Predictive Value of Cytokines and Optimizing the Entire Treatment Pathway—Research and Prospects of CD7 CAR-T as a Bridge to Transplantation
  • The 14th Lu Daopei Hematology Forum | Dr. Shu Yan: Stratified Prevention and Control, Comprehensive Management—Strategies for the Diagnosis and Treatment of Invasive Fungal Disease After Hematopoietic Stem Cell Transplantation
Recent Comments
    Archives
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top